Eastern District of North Carolina Grants Motion To Dismiss Conspiracy Claims In HVAC Refrigerant Market
03/03/2026
On February 20, 2026, Judge Terrence Boyle of the U.S. District Court for the Eastern District of North Carolina dismissed all claims against Mexichem Fluor, Inc., a producer and distributor of refrigerant products, and its co-defendant, chemicals manufacturer The Chemours Company FC, LLC. FluoroFusion Speciality Chemicals, Inc., et al. v. The Chemours Company FC, LLC, et al., No. 5:24-cv-716-BO-KS (E.D.N.C. Feb. 20, 2026). Plaintiffs FluoroFusion Specialty Chemicals, Inc. and Dynatemp International, Inc. alleged defendants conspired to monopolize the market for R-454B, a new HVAC refrigerant, by refusing to sell bulk R-454B to FluoroFusion for resale. Judge Boyle granted defendants’ motion to dismiss all claims with prejudice, finding plaintiffs failed to plausibly allege an antitrust conspiracy, monopolization or attempted monopolization, antitrust injury, or any state law claim under contract, tort or unfair competition law (UDTPA).
In 2021, the EPA began phasing out the production and use of refrigerants with substantial global warming impact and required manufacturers to switch to products like R-454B with lower global warming potential. As a result, the manufacturing defendant’s product saw a sharp increase in demand. In January 2024, defendants entered into a distribution agreement to sell R-454B, but because the distributor defendant’s primary customer relationships were in the automobile industry, it sought plaintiff’s interest in sub-distributing the product.
The parties at length attempted to negotiate the potential sale to one of the plaintiffs. Ultimately, the manufacturing defendant stepped in to impose certain terms. First, it required the plaintiff to resell the product either under the brand of the distributor defendant or as unbranded. Second, the manufacturing defendant imposed a non-disparagement provision on plaintiff, under which plaintiff would be barred from making public critical comments about the manufacturer or the product.
Plaintiff rejected these terms and filed suit along with its co-plaintiff, a downstream affiliate, alleging the terms and ultimate failure to agree were anticompetitive. Plaintiffs alleged a scheme by defendants to monopolize the market for this product and refrigerants generally, in violation of Section 1 of the Sherman Act and Clayton Act. Plaintiffs advanced several theories against both defendants, including conspiracy in restraint of trade, conspiracy to monopolize, and exclusive dealing. Plaintiffs separately asserted claims against the manufacturing defendant under Section 2 of the Sherman Act for actual and attempted monopolization. Plaintiffs also sought relief under state law for alleged breach of contract, tortious interference, and deceptive trade practices. At the core, the amended complaint asserted defendants foreclosed plaintiffs from competing in the market for the refrigerant and interfered with plaintiffs’ customer relationships.
First and foremost, the Court concluded plaintiffs did not plausibly allege an antitrust injury, failing to establish a harm of the type antitrust laws are intended to prevent. At most, the Court reasoned, plaintiffs’ injury was to their marketing and branding, as they were permitted to resell defendant’s product so long as they adhered to the manufacturer’s terms. Prospective antitrust plaintiffs are unable to dress up dissatisfaction with contract negotiations as antitrust harms, and thus, plaintiffs’ antitrust claims were unavailing. The Court rejected plaintiffs’ antitrust claims as untethered to any broader market harm.
In assessing the merits of the conspiracy claims, the Court noted that the challenged contract terms were imposed unilaterally by the manufacturing defendant, who controls the terms of its product’s distribution. Contrary to plaintiffs’ allegations of conspiracy, the distributor defendant reacted critically to the new terms but ultimately could not override the manufacturer’s requirements, demonstrating the interests of defendants were not aligned. Absent a plausible inference of collusion, the court rejected plaintiffs’ allegations of both conspiracy to restrain trade and conspiracy to monopolize. The Clayton Act exclusive dealing claims, premised on the same conduct, likewise failed.
As to plaintiffs’ Sherman Act Section 2 claims against the manufacturing defendant, the court held plaintiffs offered no facts suggesting market foreclosure beyond plaintiffs’ own ability to acquire the product under their desired terms. The Court further held plaintiffs did not plausibly allege a feasible nexus between the sales of one product and defendant’s likelihood of monopolizing a broader refrigerants market.
In addressing the state law allegations, the Court determined, based on exhibits attached to the pleading, that parties never reached a meeting of the minds on essential contract terms to create a binding agreement. The Court faulted plaintiffs for failing to demonstrate mutual assent on price and quantity of product shipments. Plaintiffs’ tortious interference and state UDTPA claims rose and fell with their other allegations.
The Court refused to grant plaintiffs’ requested declaratory judgment that the manufacturing defendant possessed no valid patent for the relevant refrigerant, as plaintiffs failed to identify the specific patent they sought to challenge.
Categories:
Antitrust Injury,
Attempted Monopolization,
Clayton Act, § 3,
Conspiracy,
Exclusive Dealing,
Monopolization,
Sherman Act § 1,
Sherman Act § 2,
Tying,
Vertical Restraints
